ArticleExperimental and therapeutic medicine2012

A population-based study of gefitinib in patients with postoperative recurrent non-small cell lung cancer.

Kinya Furukawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.